Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
enzalutamide - Google News
Get the latest updates from enzalutamide - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 3 hours ago
The State of CRPC Treatment in Spain: Expert Opinions on Enzalutamide and Abiraterone - Elena Castro & Fernando Lopez-Campos - UroToday
2 days ago
The State of CRPC Treatment in Spain: Expert Opinions on Enzalutamide and...
EMBARK Subgroup Analysis: Enzalutamide Monotherapy Effective Regardless of Prior Definitive Therapy - Stephen Freedland - UroToday
2 days ago
EMBARK Subgroup Analysis: Enzalutamide Monotherapy Effective Regardless of Prior Definitive Therapy -...
Overall Survival Results from the TALAPRO-2 Trial in mCRPC Patients - Neeraj Agarwal - UroToday
7 days ago
Overall Survival Results from the TALAPRO-2 Trial in mCRPC Patients - Neeraj...
PSMA-PET Tumor Volume Predicts Added Benefit of Lu-PSMA-617 - Medscape
14 days ago
PSMA-PET Tumor Volume Predicts Added Benefit of Lu-PSMA-617 Medscape
Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Enzalutamide for Prostate Cancer - Medical Dialogues
15 days ago
Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Enzalutamide for Prostate...
Nuances in sequencing systemic and local therapy for mHSPC - Urology Times
15 days ago
Nuances in sequencing systemic and local therapy for mHSPC Urology Times
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis - Frontiers
21 days ago
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent...
(PDF) Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer - researchgate.net
22 days ago
(PDF) Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer researchgate.net
PARP Inhibitors and Radioligand Therapies Advance Prostate Cancer Care with Biomarker-Driven Strategies - OncLive
27 days ago
PARP Inhibitors and Radioligand Therapies Advance Prostate Cancer Care with Biomarker-Driven Strategies...
UCLA research helped pave the way to these 8 major cancer-fighting drugs - University of California
28 days ago
UCLA research helped pave the way to these 8 major cancer-fighting drugs...
Astellas win strengthens blockbuster drug's European position - Life Sciences Intellectual Property Review
28 days ago
Astellas win strengthens blockbuster drug's European position Life Sciences Intellectual Property Review
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Potential Game-Changer? - MSN
about 1 month ago
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Potential Game-Changer? MSN